The RUBY study, an international prospective observational study designed for detecting biomarkers associated with persistent (≥72 h) AKI stage 3, identified urinary C–C motif chemokine ligand 14 (CCL14) as a reliable predictor of persistent AKI [45]. This evidence concerns the gene CCL14 and acute kidney injury.